Alright, sports fanatics in Nepal, let's talk 1xBet. You've probably seen the ads, heard the whispers, and maybe even considered jumping into the action. Is it worth it? Well, let's break it down, focusing on their mobile app – because let's be honest, who wants to be chained to a desktop these days?
The 1xBet app promises fast betting, live streaming, and those sweet, sweet instant withdrawals. Sounds tempting, right? They've been around since 2007, officially licensed, and claim to be 100% safe. They are supposed to be around until 2026 according to their license. But remember the fine print: 18+ only and gamble responsibly. That's non-negotiable.
Downloading and installing the app is pretty straightforward. Here's the deal:
- Download the APK file (that green button's your friend).
- Enable installation from "Unknown Sources" in your phone's security settings. It sounds scary, but it's necessary for apps not from the Google Play Store.
- Open the file and tap "Install". Boom. You're in.
What about the actual experience? The app boasts live broadcasts, instant notifications (goals, scores, promos!), and one-click betting. This is great if you want to bet quickly on live matches. But is the app any good?
Here's a quick https://1x-betnepal.com/en comparison to give you a better idea:
| Feature | 1xBet App |
| Live Streaming Quality (on average) | 720p (most matches) |
| Withdrawal Speed (using e-wallets) | Typically 1-3 hours |
| Welcome Bonus (as of Oct 26, 2024) | 100% up to 13,000 NPR |
Let's talk about those odds, too. They often advertise "high odds," and while that *can* be true, it's always smart to shop around and compare with other betting platforms. Don't just take their word for it! And remember, gambling should be fun, not a source of stress.
Customer support is supposedly 24/7, which is reassuring. Having quick access to help is always a plus.
So, should you download the 1xBet app? It depends. If you're looking for a convenient way to bet on sports, especially live, then it might be worth a shot. Just be smart, be responsible, and don't bet the farm on any one game. Gambling can be addictive, please remember that.

Leading Innovation in Blood Pressure
Our engineers, scientists, and mission-driven visionaries utilize unique datasets and deep learning algorithms, advancing beyond conventional blood pressure metrics to redefine proactive health standards.
We turn insights into action in the fight against hypertension
At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.
Aktiia Co-Founders start working
Josep and Mattia join the Swiss Centre for Electronics and Microtechnology (CSEM)
Cuffless Blood Pressure R&D Process
30+ techniques tested, 10+ studies conducted;
1 proven solution: Optical Blood Pressure Monitoring
Josep Solà defends his PhD thesis
His research on continuous non-invasive BP estimation is the technology behind Aktiia’s monitoring solutions.
Clinical Trial Confirms Accuracy of Cuffless BP Monitoring
Aktiia’s clinical trial, highlighted in Blood Pressure Monitoring journal, demonstrates its optical device’s accuracy in measuring blood pressure without cuffs, compared to traditional arterial line methods.
Aktiia's Clinical Trial Validates Cuffless BP Monitoring Versus Auscultation
Aktiia’s trial successfully compares its cuffless BP monitoring technology against traditional auscultation methods, ensuring accuracy during posture changes. This supports the device’s use for consistent 24-hour blood pressure tracking.
Aktiia is classified as a Class IIa Medical Device, adhering to the highest safety and performance standards in the European Union.
Aktiia debuts in the UK Market
Aktiia continues its expansion, offering its advanced health monitoring technologies to the UK audience.
Aktiia launches in Six European Markets
Aktiia brings its cutting-edge solution to Germany, Switzerland, France, Italy, Austria and Ireland.
Nature Cardiology Reviews features Aktiia data
Nature Publication Validates Aktiia's Blood Pressure Monitor Accuracy
Published in Nature Scientific Reports, Aktiia’s study demonstrates the consistent accuracy of its wearable blood pressure monitor across different body positions.
50 Million Blood Pressure Measurements
Aktiia Study in Nature Shows Cuffless Monitor on Par with 24-h Daytime ABPM
Aktiia’s cuffless BP monitor is validated by a Nature Hypertension study, showing equivalent accuracy to 24-hour ambulatory monitoring in cardiac rehab patients.
Study of Aktiia device in the elderly
Evaluating its performance in different body positions with auscultation as the reference measurement.
Aktiia's Global Research Footprint Expands
Aktiia’s blood pressure technology is at the forefront of medical innovation, participating in over 20 clinical trials worldwide to improve patient care and health outcomes.
It’s our mission to transform this data into programs and service that will help people live their lives free from hypertension.
The unique data from Aktiia’s automated 24/7 blood pressure solution leads to never-before-possible insights about cardiovascular health.
Aktiia’s team of experts has:

4 PhD’s in biomedical signal processing

Over 120 peer-reviewed publications

Over 35 collective patents

Member of ISO/IEEE committees

Editor of "Cuffless Blood Pressure Handbook"
Josep Solà
Chief Technology Officer
Ph.D. in Telecommunications from the Swiss Federal Institute of Technology in Zurich. Editor of the book “The Handbook of Cuffless Blood pressure Monitoring - A practical guide for clinicians, researchers, and engineers“ published by Springer
Jay Shah MD FACC
Chief Medical Officer
Practicing cardiovascular disease expert with 17+ years expertise. Previously Mayo Clinic, Mass General
Mattia Bertschi
Chief Executive Officer
Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Technology in Lausanne
Neil Puri
Head of Quality & Regulatory
15+ years in regulated industries. Held multiple leadership roles at Dexcom
Mathieu Danthony
Head of Finance
MS in Finance, CPA, 13+ years of international finance experience
Daniel Graf
President
Independent board member. Previously at Google, Uber, Twitter, Dispatch Health
Martin
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Advised by:
Dr. Grégoire Wuerzner
Principal Investigator of the pivotal validation studies, CHUV, Switzerland
M.D. Bruce S. Alpert
Plough Foundation Chair of Excellence, U of TN. American Heart Association Fellow
Naomi Fisher
Director, Hypertension Service at Brigham and Women's Hospital
Associate Professor, Harvard Medical School